Articles

Investors might be well served by expanding beyond the S&P 500.

Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts said

One analyst is “very bullish” on Micron’s stock ahead of what could be a mixed report on Wednesday. But he cautioned that a post-earnings stock bump might not last long.

Businesses are looking forward to a business-friendly Trump White House.

The newest member of the trillion-dollar market-cap club is looking ahead to a “likely sharp new product ramp” in the second half of 2025, according to an analyst.

Ford’s stock draws a downgrade as an analyst sees more underperformance ahead for the auto giant.

Yields on U.S. government debt dropped from their highest levels in a few weeks on Monday as buyers emerged during the Asian, European and early U.S. sessions.

“SoundHound represents an under-appreciated pure play AI company,” according to Wedbush analyst Dan Ives.

Goldman Sachs says investors hope for double animal spirits going forward — surging business activity that will drive stocks higher.

Tesla’s stock heads for another record, as Wedbush sees a “bull case” possibility of a rally to $650 in 2025.

Oil prices were falling on Monday morning as traders assessed a batch of economic data in China that showed retail-sales growth unexpectedly weakened in November. Still, traders remained cautious ahead of the Federal Reserve’s policy meeting later this week.

DOGE will have to go after Social Security and health programs to hit its targets. Some in Washington don’t believe it stands a chance.